TYVASO DPI TREPROSTINIL INHALATION POWDER

United Therapeutics Corporation

Application Filed: 2020-12-09

Trademark Application Details

The mark consists of the words "TYVASO/DPI" above the wording "(treprostinil) INHALATION POWDER" with two arcs to the right of the wording.

Mark For: TYVASO DPI TREPROSTINIL INHALATION POWDER® trademark registration is intended to cover the categories of pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis, where the pharmaceutical preparations contain prostaglandins. [all]

Status

2022-06-10 UTC

LIVE APPLICATION Published for Opposition

A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.

Research	OneLook Acronym Finder
Serial Number	90370409
Registration Number	6756715
Mark Literal Elements	TYVASO DPI (TREPROSTINIL) INHALATION POWDER
Mark Drawing Type	3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2022-02-18
Basis	1(a)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	Yes
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Norm J. Rich
Attorney Docket Number	080618-

Timeline

2020-10-28	Date of First Use
2020-10-28	Date of Use In Commerce
2020-12-09	Application Filed
2020-12-12	Location: NEW APPLICATION PROCESSING
2020-12-12	Status: Live/Pending
2020-12-12	Transaction Date
2022-02-18	Location: PUBLICATION AND ISSUE SECTION
2022-03-29	Published
2022-03-29	Status: Application has been published for opposition. The opposition period begins on the date of publication.
2022-06-14	Trademark Registered

Trademark Parties (Applicants & Owners)

Party:	United Therapeutics Corporation
Address	1040 Spring Street Silver Spring, MARYLAND UNITED STATES 20910
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Application		2020-12-09
Drawing		2020-12-09
Design Search Code Corr Project		2021-02-17
Offc Action Outgoing		2021-06-10
XSearch Search Summary		2021-06-10
Response to Office Action		2021-11-18
Amendment and Mail Process Complete		2021-11-19
Amendment to Allege Use		2021-11-29
Specimen		2021-11-29
AAU Processing Complete		2021-12-01
Examiners Amendment		2022-02-15
Amendment and Mail Process Complete		2022-02-17
Notice of Acceptance of AAU		2022-02-18
TRAM Snapshot of App at Pub for Oppostn		2022-02-18
Notice of Publication		2022-03-09
Notification Of Notice of Publication		2022-03-09
OG Publication Confirmation		2022-03-29
Notice of Registration-Notice		2022-06-14
Registration Certificate		2022-06-14

Design Search Codes

261709

Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved

Attorney of Record

NORM J. RICH
FOLEY & LARDNER LLP
3000 K STREET, N.W.
SIXTH FLOOR
WASHINGTON, DC 20007

Good, Services, and Codes

IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis, where the pharmaceutical preparations contain prostaglandins. FIRST USE: 20201028. FIRST USE IN COMMERCE: 20201028

International Codes:	5
U.S. Codes:	005,006,018,044,046,051,052

Type Code	Type
DM0000	The mark consists of the words TYVASO/DPI above the wording (treprostinil) INHALATION POWDER with two arcs to the right of the wording.
DM0000	The mark consists of the words "TYVASO/DPI" above the wording "(treprostinil) INHALATION POWDER" with two arcs to the right of the wording.

Trademark Filing History

Description	Date	Proceeding Number
REGISTERED-PRINCIPAL REGISTER	2022-06-14
NOTICE OF REGISTRATION CONFIRMATION EMAILED	2022-06-14
PUBLISHED FOR OPPOSITION	2022-03-29
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2022-03-29
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2022-03-09
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED	2022-02-18
USE AMENDMENT ACCEPTED	2022-02-17	81853
APPROVED FOR PUB - PRINCIPAL REGISTER	2022-02-17
EXAMINER'S AMENDMENT ENTERED	2022-02-16	96463
ASSIGNED TO LIE	2022-02-16	96463
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2022-02-15	6328
EXAMINERS AMENDMENT E-MAILED	2022-02-15	6328
EXAMINERS AMENDMENT -WRITTEN	2022-02-15	81853
USE AMENDMENT FILED	2021-11-30	88889
AMENDMENT TO USE PROCESSING COMPLETE	2021-11-30	88889
TEAS AMENDMENT OF USE RECEIVED	2021-11-29
TEAS/EMAIL CORRESPONDENCE ENTERED	2021-11-18	88889
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2021-11-18
CORRESPONDENCE RECEIVED IN LAW OFFICE	2021-11-18	88889
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2021-06-10	6325
NON-FINAL ACTION WRITTEN	2021-06-10	81853
NON-FINAL ACTION E-MAILED	2021-06-10	6325
ASSIGNED TO EXAMINER	2021-05-28	81853
NOTICE OF DESIGN SEARCH CODE E-MAILED	2021-02-17
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2021-02-16
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	2021-02-16
NEW APPLICATION ENTERED IN TRAM	2020-12-12
NEW APPLICATION ENTERED	2020-12-12